The global medtech industry has been growing rapidly over the last decade and is expected to continue to offer strong growth prospects over the coming years due to demographic changes and higher standards of care.
Besides offering global medtech corporations strong growth prospects, the Asia Pacific region is also an attractive market for new start-ups. In Singapore, for example, the number of home-growth medtech companies has increased from 100 in 2014 to about 300, and over half of these were start-ups. Many of these medtech start-ups are exploring breakthrough innovations which are sparking global interest and attention.
Amongst our Corporate Members, we have 20 of the top 30 global medical device manufacturers. These global medtech corporations continue to provide tangible benefits for the region’s research, innovation and enterprise and healthcare systems. However, it is important to consider a holistic medtech innovation ecosystem involving the start-ups as they drive innovation and develop life-changing technologies. Nurturing MedTech startups is one of the strategic pillars of APACMed’s strategy.
Medical device, diagnostic and digital health start-ups are a vital part of the MedTech ecosystem, as they drive innovation and develop life-changing technologies. Nurturing MedTech founders is one of the strategic pillars of APACMed strategy. We have launched the Founders Series to stimulate ecosystem collaboration and build relevant capabilities through industry workshops and mentorships & partnerships. We hope that the Founders Series would help our start-ups shorten their time to market, develop outcome-based partnerships, and increase the possibility of attracting investment. There are three components to the program: Founders Campus, Founders Collaborate and Founders Circle.
If you are are a MedTech start-up or SME and want to find out more about how APACMed can help you by leveraging on our expertise and network to help you grow.Please contact Gabriel Sim, Director of Strategic Partnerships at APACMed at [email protected] he will get in touch with you. Email Gabriel
Stimulate the entrepreneurship of medical devices, diagnostics and digital health with programs (e.g. webinars, workshops) delivered by industry executives and advisors with diversified experiences. Founders Campus focuses on different growth paths, discussing everything from the must-knows of IP, regulatory and reimbursement to the best ways to secure funding.
Join MedTech Innovator, the industry’s non-profit global competition and accelerator for medical device, digital health and diagnostic companies. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator is the largest platform of its kind, providing participants with broad exposure to the leading players in the medtech industry. In the Asia-Pacific program, MedTech Innovator Showcase startups will receive mentorship and coaching through one-on-one matching with one or more mentors from its corporate partners to help with commercialization.
Facilitate mentoring relationships for founders and entrepreneurs within the MedTech industry with promising medical device, diagnostic and digital health start-ups. APACMed matches these start-ups with highly skilled volunteer senior business leaders from the industry to help them to succeed in the development and launch of their innovation.
Alvin Hew is the Vice President Marketing Orthopaedics, APAC for Smith and Nephew Ptd Ltd. In this role, he has responsibility for the marketing and strategy of the SNN Orthopaedic Robotic strategy, which includes the Navio Orthopaedic Robot, Brainlab Ortho Navigation suite and the Atracys optical imaging portfolio.
Previously, he was the General Manager for the MITG Group for Medtronic South East Asia from January 2017 to Dec 31, 2018. I. Prior to taking on this role, he was Vice President, Regional Marketing for Surgical Innovations for Medtronic in the Asia Pacific Region. He was responsible for the marketing, strategic direction and integration of new products and technologies within the Surgical Innovation APAC region which included the Surgical Robot, and Early technologies portfolio.
He has 25 years of experience in the Asia Pacific medical device industry through roles in sales, regional marketing and general management. Before joining Covidien, Alvin worked at Cordis, a Johnson and Johnson company, for 16 years based in Singapore and Seoul.
Alvin is a global business leader with extensive field experience within APAC and was educated and grew up in Toronto, Canada. Alvin holds a Bachelor of Science, from Queen’s University, Canada. He also holds an MBA from the University of Chicago Booth School of Business.
Anh Bourcet is currently Regional Director, Health Economics & Market Access, in Johnson & Johnson. In this role, Anh has been driving the Asia-Pacific strategy for Global Orthopedics, articulating and demonstrating the value of innovation, leveraging real-world evidence and access strategies. She is chair of the Asia-Pacific Medical Technology Association Digital Reimbursement Working Group & active member of the Government Affairs & Market Access Group.
Anh has about 10 years of experience with an in-depth understanding of healthcare systems in Asia-Pacific and Europe, both in the medical devices and pharmaceutical industries. Anh is passionate about patient outcomes, evidence-based medicine and new technology solutions to improve patient care.
She started in Janssen France in Medical Affairs, then worked for the French Health Safety Agency on innovative Medical Devices. Her report and recommendations on the regulatory framework paved the way for the European Commission to build their guidelines for Innovations containing nanomaterials. She returned to Janssen Medical Affairs Asia-Pacific, when moving back to Asia, before transitioning to the Medical Device sector and to Health Economics & Market Access function.
Anh holds a PhD cum laude in Medicinal Chemistry from Paris VI & “Chimie ParisTech” Universities (France), and an Executive Master in Health Industry Management, ESSEC Business School (France). She has authored many peer-reviewed publications and spoken in various scientific and healthcare conferences.
Biten Kathrani is the Head of R&D for Asia Pacific for Johnson & Johnson Vision Care. Based in Singapore, he represents APAC region in the Vision Care R&D Leadership team and is responsible for developing and leading R&D programs, partnerships and innovation in eye health in the APAC region. He is also responsible for leading J&J Vision strategic Myopia Research Collaboration program with Singapore National Eye Center / Singapore Eye Research Institute.
Biten has been in the healthcare / medtech industry for 25 years leading R&D, Innovation and new ventures in APAC (China and India) and USA. He has led medtech R&D organizations in Asia Pacific for Johnson & Johnson (between 1999 to 2014), Boston Scientific (between 2014-2018) and at a start-up (1994 – 1999). He has been instrumental in setting up APAC R&D centers for J&J’s surgery businesses in India and China and Boston Scientific’s Global R&D Center in India. He has lead R&D programs and talented teams to deliver 15+ diverse medical devices and 50+ patents covering single use disposable devices, capital equipment & instruments and software & connected health platforms for Class III implantables.
He has had the opportunity to work across 8+ disease states including General Surgery and Endoscopy, Orthopedic surgery, Diabetes, Interventional Cardiology, Nephrology, Neuromodulation, and most recently Eye Health.
He has been proponent of Design Thinking and Customer needs & Insights driven innovation and has been associated with the Stanford Biodesign program since 2009. He is also a member of the Founders Forum, a volunteer organization setup by Stanford Biodesign alumni to support medtech startups through their commercialization and scale up journey in India. During his tenure with Boston Scientific in India, he was an active member of Global In-house Capability (GIC) committee, North India Chapter at NASSCOM. Boston Scientific’s Global India R&D center won the NASSCOM Innovation Excellence Award for GIC’s (Global Inhouse Capability Centers) in India in April 2018.
Biten holds an MBA from the ivy league Wharton Business School, an M. Tech in Biomedical Engineering from IIT Mumbai; and he is a certified Patent Agent with the India Patent Office. He has launched more than 15 products and has several granted patents in this name.
Fredrik is the Managing Director Asia Pacific at MedTech Innovator, based in Singapore. He was most recently the Founding CEO of Asia Pacific Medical Technology Association (APACMed). Fredrik brings over 30 years of healthcare industry experience, 25 of which were spent in Asia-Pacific. He has held senior sales/marketing, general management and strategic consulting positions. Fredrik serves as Board Member and advisor to several medtech/digital health startup ventures and is a frequent speaker on the healthcare industry in Asia-Pacific. He holds a BSc from Gothenburg University, Sweden, and an MBA from Henley Management College, UK.
Matthew Chapman is the Executive Director, Asia Pacific for Surgical Solutions at HillRom. In this role Matthew is responsible for the Surgical Solutions business performance across China, Japan, SEA, Korea, and Australia/NZ. Surgical Solutions at HillRom aims to improve surgical workflow and connectivity for caregivers and patients.
Matthew began his career with GE Healthcare working across sales and sales enablement roles within the United States. In 2013 he joined CR Bard in Shanghai, China and subsequently held various responsibilities including China marketing, international market development, and emerging market strategy. Most recently, Matthew was responsible for European Marketing, Surgery with BD (Becton Dickenson) based in Paris, France. In March 2020 Matthew joined HillRom and relocated his family to Singapore.
Matthew earned an MBA from HULT International Business School (Dubai/Shanghai) and Bachelors Degree in International Business from Washington and Jefferson College (USA).
Paula has over 15 years of international business experience in technology-based industries in various leadership positions and geographies, with 2.5 years of experience in Asia Pacific.
Paula is part of the Asia Pacific Business Development Group at Roche Diagnostics, the world’s largest manufacturer of In Vitro Diagnostics Solutions. She leads the team responsible to drive digital and business innovation in the region (16 markets), through a series of transformation initiatives. Before joining Roche, she held senior digital roles at Alstom/GE Power Generation and General Motors Europe.
Paula graduated from Pontificia Universidad Catolica de Chile with a Masters Degree in Journalism and Social Information.
Leon is a veteran in the healthcare industry with over 20 years of management and executive experience across Asia Pacific and is currently the Vice President and GM in Merit Medical responsible for developing Merit’s business and strategy in Asia. Being the first staff in 2010, Leon led Merit’s establishment in China, subsequently expanded across Asia and has since enjoyed uninterrupted high double-digit growth in organization size, revenue, and profits. Previously he held various leadership positions in Stryker China and Asia Pacific.
Leon is a global executive with extensive experience in APAC. He received his bachelor education in life science from the University of Toronto, Canada, his MPhil degree in Neuroscience and Doctor of Business Administration from Hong Kong. He is a graduate of executive programs from Harvard Business School and Ross School of Business, University of Michigan. Leon is also a Registered Six Sigma Champion™ and a certified business coach from the Worldwide Association of Business Coaches. He has lived in Toronto, Beijing and currently resides in Hong Kong.
With a passion in giving back his knowledge and experience, Leon is regularly invited to give guest lectures to MBA and MSc Marketing students and speaks in regional industrial conferences. He is also a visiting lecturer in the Institute of Entrepreneurship, The Hong Kong Polytechnic University.
Seemant brings 19 years of experience in Healthcare Innovation, business consulting, & strategy. Seemant leads HealthXCapital, the first early stage healthcare VC in South and South east Asia. HealthXCapital is backed by marquee institutions and partners such as Apollo Hospitals, Jungle Ventures, Eight Road Ventures and Enterprise SG amongst others. Until recently, he was the CEO – Innovations & Research at Apollo Hospitals. He spearheaded Apollo’s initiatives to scout, evaluate, invest and commercialize innovations. During his tenure, Seemant has evaluated more than 300 startups for joint ventures, commercial agreements and direct investments. Seemant also served as a Director on the board of multiple Apollo Hospitals joint venture entities focused on bio-banking, cord blood banking and clinical trials. In his previous assignments, Seemant has had diverse experience across business consulting at Ernst & Young, Strategy and transformation at Nokia Solutions Networks and IT consulting at Tata Consultancy Services.
Seemant is a graduate of Business Indian School of Business (ISB) with executive education from Berkeley-Haas and Recanati Business School, Tel Aviv. He has a Bachelors in Engineering from the Birla Institute of Technology.
Miang holds a Bachelor of Pharmacy degree of Chulalongkorn University and MBA degree of Mahidol University in Thailand.
She has had more than 22 years of regulatory affairs experience with numbers of Healthcare companies. During this time, her current position is the Regional Regulatory Affairs and Government Affairs head, Asia Pacific including the role of a member of senior leadership team of Alcon Asia Pacific.
Miang has a board experience in Regulatory Affairs, Clinical Research, Reimbursement, Government Affairs and Quality Assurance in Asia Pacific including Japan. Prior to Alcon Miang has worked for numbers of MNC (Takeda & Boston Scientific, J&J, Actelion, Cochlear & Bausch & Lomb) in different locations (Bangkok, Hong Kong, Sydney and Singapore and Zimmer Asia Pacific) for both Pharma and Devices industries.
In addition, she has been heavily involved with numbers of harmonization activities including GHTF, AHWP and ACCSQ. She was invited to be one of the speakers and consultants of Malaysian MOH during their early stage of medical devices regulatory framework formalization. Recently, she was also nominated to be one of the experts in medical devices area to WHO. She was an industry co-chair of AHWP TC and one of the members of GHTF SG02 (Postmarket Surveillance). Currently, she is an APACMED chair of Regulatory committee and AHWP TC secretariat.
Paul Chua will be responsible for improving the security of BD products and solutions that are sold to customers across Greater Asia by design, in use
and through partnership. Paul will oversee and direct the adoption of the corporate product security framework within the Greater Asia region and
various other aspects of the overarching product security program across the BD product portfolio (e.g. risk assessment, awareness/training, incident
response, strategic initiatives, and external engagements) in addition to reporting progress to Regional Leadership. He will utilize available corporate resources with expertise in security testing, architecture, incident response, and program management in addition to ensuring BD’s broader
efforts comply with local law and regulations within the region.
Paul is a seasoned professional with more than 23 years of experience
managing product development, sales/marketing and operations at APAC level across IT, Telecommunications, Cybersecurity, and Homeland Security industries for established multinational companies such as Motorola, Airbus; government agencies, such as Ministry of Home Affairs; and early stage startups. He had helped to conceptualize and build large-scale Command & Control (C2) systems, Decision Support Systems (DSS), Security Operation
Centers (SOC) and Smart & Safe City Projects across Asia Pacific. Prior to joining BD, Paul was the Chief Product Officer of a Singapore data analytics
startup, where he was responsible for developing multiple Data Analytics as a Service and Data Fusion as a Service products for the BFSI, Maritime,
Cybersecurity and Government enterprises.
Paul holds a Bachelor of Applied Science (Computer Engineering) from Nanyang Technological University in Singapore and a joint Masters of Business Administration from Northwestern University, Kellogg School of Management & Hong Kong University of Science and Technology. Paul is a Certified Information Systems Security Professional (CISSP) and a CREST Registered Threat Intelligence Analyst (CRTIA). He is currently based in Singapore.
Aalok is the General Manager for South East & North Asia at Hillrom. Prior to his current role, he served in senior management roles in marketing, sales, general management, M&A in Hillrom, Laerdal, Philips and GB Foods. He has more than 17 years of international experience in building commercial organizations across five continents in healthcare and consumer goods sectors.
Hillrom proudly envisions itself as the future leader in connected healthcare. He has made significant contributions in shaping the digital strategy of Hillrom not only in APAC but also globally. During Hillrom’s corporate development stint, he was instrumental in identifying, evaluating and integrating acquisitions of Mortara, PediaVision, Welch Allyn. At Philips, he championed a multi-pronged approach focused on clinicians, providers, payors and patients to improve quality of life for people suffering from sleep disorders in Asia. Leading a medical training firm – Laerdal, he created programs with various Govt agencies in ASEAN region to upskill younger healthcare professionals to adapt to rapidly changing healthcare needs.
He is a proud recipient of eHealthcare leadership award (Campaign Asia) and Interactive Media Award for best patient campaign in 2014.
He believes his playbook for unlocking markets’ potential leveraging his truly global experience and is ever evolving. His playbook has few healthcare relevant chapters, the most important one is centered around the passion to drive better patient outcomes or enhance clinician productivity and demonstrate measurable impact.
Steven Bell holds the position of Senior Vice President for Diagnostic Imaging and Digital Health – APAC with Siemens Healthineers and is principle executive coach with EV Executive Coaching. After starting his career in medical imaging and working in a number of hospitals in Melbourne, Steven joined Siemens Healthineers in 2004 and has since worked in a number of positions in APAC and Europe. Steven now lives back in his beloved home-town of Melbourne.
Steven holds a degree in Applied Science, a Graduate Degree in Applied Finance and Investment, and an MBA from Curtin University. In addition, Steven has studied International Corporate Coaching and Advanced professional Coaching with Singapore Management University and Progress-U and is a Registered Corporate Coach™ with the World Association of Business Coaches.
As someone deeply passionate about continual improvements in healthcare, Steven is always keen to engage in conversations about the latest developments in diagnostic imaging and digital health. Of particular interest is how caring humans come together with cutting-edge engineering and IT to deliver outcomes that matter to patients.
Sameer Singla is currently Director for Chronic Care franchise at Avanos Medical. He leads Digestive and Respiratory health businesses, across Asia Pacific – wherein he drives strategy and marketing executions. In the last year and a half with Avanos, he has also had the roles of interim country manager for Japan and Australia.
Prior to Avanos, Sameer spent about 10 years at Johnson & Johnson working in various businesses. He led Advanced Sterilization Products, to achieve the highest growth for the STERRAD low temperature sterilizers in India. As the head of Depuy Synthes for South Asian markets, he drove investments in professional education and shaped the healthcare environment, for the orthopedics implant business. And, he led sales for Neuro Surgery and Spine business units, while managing their post-merger integration.
Over the years, Sameer has worked in multiple geographies and commercial leadership roles, however he started his career as a game developer, working on title such as “Romance of Three Kingdoms Online” with KOEI Corp. Ltd., in Japan and Singapore.
Sameer is passionate about people development and coaching. He holds a Master’s in Business Administration from London Business School. MS in Computer Science from National University of Singapore (Singapore-MIT Alliance program) and BE in Computer Science from Bangalore University in India. A native English and Hindi speaker, he also continues to learn Japanese.
Sharad Mi. Shukla, RAC is currently heading the regulatory affairs (Medical Devices) for South East Asia at Johnson & Johnson Medical. Sharad has over seventeen years of experience in MedTech industry with hands-on in Design & Development, Manufacturing, Clinical, Quality & Regulatory Affairs.
Prior to Johnson & Johnson, Sharad worked with GE Healthcare as Global Regulatory Affairs Leader and was responsible for leading multiple strategic regulatory projects including NPI’s for anesthesia, respiratory & maternal infant care devices. In his previous experience he worked with European certification/ notified body as ISO 13485 & CE Marking lead auditor for medical device. He worked with different start-ups as well and has been instrumental in establishing Quality & regulatory functions & services from the scratch and devising regualtory strategies for global markets. With his strong passion for training and capacity building for quality & regulatory professionals, he is actively engaged with regulatory shaping and advocacy with different industry forums. Recently, he is elected as Chair of Capacity Building Workgrop for the APACMed RA Committee.
Sharad has a MS in Microbiology. He also earned Regulatory Affairs Credentials (RAC) for US & EU from RAPS, USA and actively engaged with RAPS as technical expert & author. He has also moderated multiple RAC study groups for regualtory professionals.
As a member of KPMG’s Global Healthcare & Life Sciences Centre of Excellence, Chris is presently based in Singapore looking after developments in the Asia-Pacific region. Prior postings have included Europe, US, and Brasil. With experience across a range of geographies and project types, his passion is public-private partnerships to drive innovate, safe, and economically-viable initiatives in the sector. In addition, Chris engages in adjunct lecturing, research/writing, and start-up/fund advisory so as to be a steward of innovation acceleration across the healthcare ecosystem.
Ren Jun Lim is a principal with Baker McKenzie Wong & Leow. He represents local and international clients in both contentious and non-contentious intellectual property matters. He also advises on a full range of healthcare, as well as consumer goods-related legal and regulatory issues.
Ren Jun co-leads Baker McKenzie Wong & Leow’s Healthcare as well as Consumer Goods & Retail industry groups. He sits on the Law Society of Singapore IP Committee and on the Executive Committee of the Association of Information Security Professionals. He is also a member of the Vaccines Working Group, Singapore Association of Pharmaceutical Industries, a member of the International Trademark Association, as well as a member of the Regulatory Affairs Professionals Association.
Ren Jun is ranked in the Silver tier for Individuals: Enforcement and Litigation and Individuals: Prosecution and Strategy, and a recommended lawyer for Individuals: Transactions by WTR 1000, 2020. He is also listed in Asia IP’s Best 50 IP Expert, 2020, recognised as a Rising Star by Managing IP: IP Stars, 2019 and one of Singapore’s 70 most influential lawyers aged 40 and under by Singapore Business Review, 2016. Ren Jun was acknowledged by WTR 1000 as a “trademark connoisseur who boasts supplementary knowledge of regulatory issues in the consumer products industry.” He was also commended by clients for being “very responsive to enquiries and with a keen eye for detail, he is extremely hands-on. His meticulous and in-depth approach to strategising is key to the excellent outcomes we enjoy.”
Hamish King is a lawyer by training, admitted in NSW, Australia and Hong Kong, and supports companies with difficult regulatory affairs queries for China. He was formerly with Linklaters in Hong Kong and regularly writes articles on China market access and regulatory pathways. Currently residing in Hong Kong and specialising in NMPA registration of medical devices, Hamish has a close interest in the regulatory implications of digital healthcare and AI applications.
Joshua is the General Manager at the MedTech Actuator in Singapore. The MedTech Actuator is founded by serial MedTech Entrepreneurs and health policy experts who understand that MedTech, HealthTech and BioTech ventures require a bespoke acceleration model, and we connect the regions’ broad ecosystems to empower founders to build the next wave of global MedTech, HealthTech and BioTech success stories.
Within the role in MedTech Actuator, Joshua is responsible for driving the strategy, partnership, and business development activities. Prior to joining the MedTech Actuator, Joshua has led early stage innovation programmes in a Large Local Enterprise as well as has held positions in new product development, strategy planning, and investments in early stage healthcare innovations.
Joshua holds a Masters of Engineering (Biomedical Engineering) from the National University of Singapore.
Nathan is APAC business head at Larsson Creative Group. He is responsible for sourcing new BD opportunities across the Asia Pacific for the company group, providing business strategy and market opportunity insights to clients in the healthcare sector.
He has extensive experience in innovation development and international business with 10+ years of experience in China, Europe, and US markets.
He supports his customers in managing global business transformation, which involves market insights, supply chain sourcing, and business strategy development. With an in-depth knowledge of MedTech organizations and Medical R&D projects, he successfully drives digital healthcare, business innovation, and medical R&D projects.
Previously, he worked as a senior medical designer at multinational firms such as Johnson & Johnson, Boston Scientific and held different managing positions at other international companies. He has managed multiple business and R&D projects with Sino-German background and has helped his clients build their business from zero to Mio. Euro revenue. With a robust clinical knowledge foundation and technological approach, Nathan demonstrated a track record as an inventor of patented medical solutions and turned them into commercialized products.
Britta Pukall is CEO and member of the board of milani design & consulting AG and larssoncreative group. She studied design in Vienna and from the Swiss elite University St. Gallen she holds an EMBA. She is responsible for the company’s business strategy development and manages the strategic implementation of huge projects in the areas of design and services together with her team of experts. Britta is characterized by her power of inspiration and innovation, her distinctive profound experience in design for international companies and complex strategy projects. She herself supervised over the past 25 years countless Medtec design projects for clients such as Dräger, Zeiss, Phonak/Sonova or Ivoclar Vivadent. In her role as an entrepreneur and investor she convinces by bringing powerful ideas to life with management know how, creativity and empathy.
Objectives of the Start-up and SMEs Committee: